Search results
Results from the WOW.Com Content Network
The Pharmacovigilance Program makes these reports itself, but ideally, such reports could originate from any clinic. [3] The Pharmacovigilance Programme seeks to encourage a culture and social expectation of reporting drug problems. [3] One of the successes of the program was detecting adverse effects of people in India using carbamazepine.
The Society of Pharmacovigilance, India (SoPI), is an Indian national non-profit scientific organisation, which aims at organizing training programmes and providing expertise in pharmacovigilance and enhance all aspects of the safe and proper use of medicines [1]
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices.It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union.
Some further PV regulatory examples from the pharmerging nations are as follows. In India, the PV regulatory authority is the Indian Pharmacopoeia Commission, with a National Coordination Centre under the Pharmacovigilance Program of India, in the Ministry of Health and Family Welfare.
Centre of Advanced Study in Botany [12] (Natural Resource) Varanasi: Centre for the Study of Developing Societies (CSDS) (Civil Service) Delhi: Centre for Development of Advanced Computing (Computer Application, Electronics) Bengaluru, Chennai, Delhi, Hyderabad, Kolkata, Mohali, Mumbai, Noida, Patna, Pune, Silchar, Thiruvananthapura
Centre for Research in Medical Entomology (CRME), Madurai; National Institute of Immunohaemotology (NIIH), Mumbai; Enterovirus Research Centre (ERC), Mumbai; Genetic Research Centre (GRC), Mumbai; National Institute for Implementation Research on Non-Communicable Diseases (NIIRNCD), Jodhpur; Regional Medical Research Center (RMRC), Port Blair
Clinical trials in India refers to clinical research in India in which researchers test drugs and other treatments on research participants. NDCTR 2019 and section 3.7.1 to 3.7.3 of ICMR guidelines [ 1 ] requires that all researchers conducting a clinical trial must publicly document it in the Clinical Trials Registry - India .
Pages in category "Regulatory agencies of India" The following 48 pages are in this category, out of 48 total. ... Pharmacovigilance Programme of India;